As of June 8th 2023 Finnish stock listed company Boreo Plc has acquired entire share capital of Delfin Technologies Ltd. We will continue operating under the name of Delfin Technologies Ltd as part of Boreo’s Electronics Business Area.
We would like to inform our customers and partners that our operations will continue as normal. Our head office will stay in Kuopio, Finland.
We are extremely proud to continue our story with Boreo Plc!
Delfin Technologies Ltd
Conclusion
A Platform for Precision, Portability and Progress
TDC measurement is no longer just a research tool — it’s a clinically valuable, field-proven solution for objective edema assessment. With Delfin’s LymphScanner, healthcare providers gain access to real-time, actionable data that improves diagnostics, enhances therapy monitoring, and supports evidence-based care.
At the same time, medical researchers are leveraging the same technology to explore new frontiers in skin and soft tissue science — including breast edema, lower limb lymphedema, head and neck swelling, and midline edema.
Whether you're treating lymphedema or designing the next clinical study, Delfin's TDC devices empower you with precision you can trust — in the palm of your hand.
